← Insider buys
CRVS

Corvus Pharmaceuticals, Inc. · Healthcare

Novo Holdings A/s sold $6.1M of Corvus Pharmaceuticals, Inc.

10% owner

Sold$6,077,845
$4.07Price
1,492,956Shares
−34%Stake

What CRVS did after the filing

Prices for CRVS after this filing aren't in yet.

Traded Tue, Jul 23. Filed Thu, Jul 25, 7:21 PM ET, after the close. Not investment advice.